Financials Southern Acids (M)

Equities

SAB

MYL5134OO001

Commodity Chemicals

End-of-day quote BURSA MALAYSIA 06:00:00 2024-04-25 pm EDT 5-day change 1st Jan Change
3.3 MYR +1.54% Intraday chart for Southern Acids (M) +4.43% +4.76%

Valuation

Fiscal Period: March 2018 2019 2020 2021 2022 2023
Capitalization 1 534 521.7 383.4 514.9 527.2 493
Enterprise Value (EV) 1 360 322.2 185.7 282.2 230.3 114.4
P/E ratio 16.2 x 24.3 x 12 x 13.8 x 5.58 x 14.8 x
Yield 1.28% 1.31% 1.79% 1.33% 1.3% 1.39%
Capitalization / Revenue 0.7 x 0.86 x 0.58 x 0.69 x 0.45 x 0.45 x
EV / Revenue 0.47 x 0.53 x 0.28 x 0.38 x 0.19 x 0.1 x
EV / EBITDA 5.74 x 5.94 x 2.73 x 3.46 x 1.33 x 1.16 x
EV / FCF 16 x 17.8 x 16.8 x 13.2 x 5.8 x 1.26 x
FCF Yield 6.24% 5.61% 5.97% 7.56% 17.2% 79.3%
Price to Book 0.91 x 0.87 x 0.65 x 0.81 x 0.72 x 0.65 x
Nbr of stocks (in thousands) 136,934 136,934 136,934 136,934 136,934 136,934
Reference price 2 3.900 3.810 2.800 3.760 3.850 3.600
Announcement Date 7/30/18 7/31/19 8/25/20 7/29/21 7/29/22 7/28/23
1MYR in Million2MYR
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: März 2018 2019 2020 2021 2022 2023
Net sales 1 763.1 603.8 666.1 745.9 1,181 1,107
EBITDA 1 62.69 54.28 67.97 81.48 172.7 98.57
EBIT 1 47.02 38.52 49.4 60.92 150.6 75.7
Operating Margin 6.16% 6.38% 7.42% 8.17% 12.75% 6.84%
Earnings before Tax (EBT) 1 51.39 38.57 48.74 60.34 149.9 74.91
Net income 1 32.94 21.48 32 37.36 94.42 33.29
Net margin 4.32% 3.56% 4.8% 5.01% 8% 3.01%
EPS 2 0.2405 0.1569 0.2337 0.2728 0.6895 0.2431
Free Cash Flow 1 22.46 18.08 11.08 21.32 39.72 90.74
FCF margin 2.94% 2.99% 1.66% 2.86% 3.36% 8.2%
FCF Conversion (EBITDA) 35.83% 33.3% 16.3% 26.17% 23% 92.05%
FCF Conversion (Net income) 68.19% 84.14% 34.62% 57.08% 42.06% 272.55%
Dividend per Share 2 0.0500 0.0500 0.0500 0.0500 0.0500 0.0500
Announcement Date 7/30/18 7/31/19 8/25/20 7/29/21 7/29/22 7/28/23
1MYR in Million2MYR
Estimates

Balance Sheet Analysis

Fiscal Period: March 2018 2019 2020 2021 2022 2023
Net Debt 1 - - - - - -
Net Cash position 1 174 200 198 233 297 379
Leverage (Debt/EBITDA) - - - - - -
Free Cash Flow 1 22.5 18.1 11.1 21.3 39.7 90.7
ROE (net income / shareholders' equity) 5.92% 3.94% 6.01% 7.03% 15.4% 6.37%
ROA (Net income/ Total Assets) 4.14% 3.32% 4.23% 4.97% 10.6% 4.87%
Assets 1 796.4 646.4 756 752.4 892.3 683
Book Value Per Share 2 4.280 4.390 4.340 4.660 5.310 5.510
Cash Flow per Share 2 1.270 1.460 1.530 1.770 2.350 2.820
Capex 1 34.5 39 15.8 23 20.4 25.8
Capex / Sales 4.51% 6.45% 2.38% 3.08% 1.73% 2.33%
Announcement Date 7/30/18 7/31/19 8/25/20 7/29/21 7/29/22 7/28/23
1MYR in Million2MYR
Estimates
  1. Stock Market
  2. Equities
  3. SAB Stock
  4. Financials Southern Acids (M)